Breaking News
January 22, 2019 - New machine learning algorithms identify early symptoms of urinary tract infections
January 22, 2019 - A global influenza pandemic high on the WHO’s agenda
January 22, 2019 - Amgen Makes All Repatha (evolocumab) Device Options Available In The US At A 60 Percent Reduced List Price
January 22, 2019 - Elastronics—hydrogel-based microelectronics for localized low-voltage neuromodulation
January 22, 2019 - Branched-chain amino acids in tumors can be targeted to prevent and treat cancer
January 22, 2019 - Fueling macrophages with energy to attack and eat cancer cells
January 22, 2019 - Amgen And UCB Receive Positive Vote From FDA Advisory Committee In Favor Of Approval For Evenity (romosozumab)
January 22, 2019 - Does being bilingual make children more focused? Study says no
January 22, 2019 - Study reveals new genes and biological pathways linked to osteoarthritis
January 22, 2019 - FSU study provides better understanding of spinal cord injuries
January 22, 2019 - Delaying bath for newborn babies increases breastfeeding rates, finds study
January 21, 2019 - WHO identifies non-communicable diseases as major threat to human health
January 21, 2019 - Many parents still try non-evidence-based cold prevention methods for children
January 21, 2019 - High Levels of Activity, Motor Ability Linked to Better Cognition
January 21, 2019 - Killer blows? Knockout study of pair of mouse MicroRNA provides cancer insight
January 21, 2019 - Buffalo researchers receive grant to quicken development of generic equivalents of contraceptives
January 21, 2019 - One-third of pregnant women do not believe cannabis is harmful to their fetus
January 21, 2019 - Fiderstat could be used as chemopreventative drug for intestinal cancers caused by APC gene mutations
January 21, 2019 - Modifying healthcare delivery practices may improve discussions between youth and healthcare providers
January 21, 2019 - UNIST researcher named as recipient of Merck’s 2018 Life Science Awards
January 21, 2019 - How Getting a Flu Shot Could Save Your Life
January 21, 2019 - Surgical adhesions can be treated, prevented in mice
January 21, 2019 - Increased physician-targeted marketing associated with higher opioid overdose deaths
January 21, 2019 - Researchers uncover specific microbial signatures of intestinal disease
January 21, 2019 - Researchers discover new blood vessel system in bones
January 21, 2019 - Simple blood test reliably detects signs of Alzheimer’s damage before symptoms
January 21, 2019 - Study to investigate new targeted oral treatments for severe asthma
January 21, 2019 - Plan Your Plate | NIH News in Health
January 21, 2019 - Fecal occult blood test may improve CRC outcomes in some
January 21, 2019 - Blood test detects Alzheimer’s disease years before symptoms develop
January 21, 2019 - Mount Sinai joins with Paradigm and ReqMed to repurpose drug for treatment of MPS
January 21, 2019 - FDA Advisory Committee Votes on Zynquista (sotagliflozin) as Treatment for Adults with Type 1 Diabetes
January 21, 2019 - The causes and complications of snoring
January 21, 2019 - Placenta adapts and compensates when pregnant mothers have poor diets or low oxygen
January 21, 2019 - New implant could restore the transmission of electrical signals in injured central nervous system
January 21, 2019 - Rapid-acting fentanyl test strips found to be effective at reducing overdose risk
January 21, 2019 - Coronary Artery Calcium May Help Predict CVD in South Asians
January 21, 2019 - The mystery of the super-ager
January 21, 2019 - Scientists develop smart microrobots that can change shape depending on their surroundings
January 21, 2019 - Keep Moving to Keep Brain Sharp in Old Age
January 21, 2019 - Despite progress, gay fathers and their children still structurally stigmatized
January 21, 2019 - New drug for treating liver parasites in vivax malaria
January 21, 2019 - Merck recognized with 2018 Life Science Industry Award for best use of social media
January 21, 2019 - Coeur Wallis equips the canton of Valais with 260 SCHILLER defibrillators
January 21, 2019 - Scientists propose quick and pain-free method for diagnosing kidney cancer
January 21, 2019 - Signs of memory loss could point to hearing issues
January 21, 2019 - HeartFlow Analysis shows highest diagnostic performance for detecting coronary artery disease
January 21, 2019 - How Much Caffeine is Too Much?
January 21, 2019 - Take a timeout before you force your child to apologize
January 21, 2019 - Scientists design two AI algorithms to improve early detection of cognitive impairment
January 21, 2019 - Novel therapy for children with chronic hormone deficiency provides lifeline for parents
January 21, 2019 - Bioethicists call for oversight of poorly regulated, consumer-grade neurotechnology products
January 21, 2019 - Study shows hereditary hemochromatosis behind many cancers and joint diseases
January 21, 2019 - Short bouts of stairclimbing throughout the day can improve cardiovascular health
January 20, 2019 - Liver Transplant Survival May Improve With Race Matching
January 20, 2019 - Study implicates hyperactive immune system in aging brain disorders
January 20, 2019 - Cancer Diagnosis May Quadruple Suicide Risk
January 20, 2019 - Parkinson’s disease experts devise a roadmap
January 20, 2019 - Research brings new hope to treating degenerative brain diseases
January 20, 2019 - Scientists pinpoint a set of molecules that wire the body weight center of the brain
January 20, 2019 - Researchers get close to developing elusive blood test for Alzheimer’s disease
January 20, 2019 - UCLA researchers demonstrate new technique to develop cancer-fighting T cells
January 20, 2019 - Researchers discover how cancer cells avoid genetic meltdown
January 20, 2019 - Exercise makes even the ‘still overweight’ healthier: study
January 20, 2019 - University of Utah to establish first-of-its-kind dark sky studies minor in the US
January 20, 2019 - School-based nutritional programs reduce student obesity
January 20, 2019 - Improved maternity care practices in the southern U.S. reduce racial inequities in breastfeeding
January 20, 2019 - New enzyme biomarker test indicates diseases and bacterial contamination
January 20, 2019 - Republican and Democratic governors have different visions to transform health care, say researchers
January 20, 2019 - Researchers discover that spin flips happen in only half a picosecond in the course of a chemical reaction
January 20, 2019 - Suicide Risk Up More Than Fourfold for Cancer Patients
January 20, 2019 - Doctors find 122 nails in Ethiopian’s stomach
January 20, 2019 - UV disinfection technology eliminates up to 97.7% of pathogens in operating rooms
January 20, 2019 - Researchers discover mechanism which drives leukemia cell growth
January 20, 2019 - AHA: Infection as a Baby Led to Heart Valve Surgery for Teen
January 20, 2019 - Injection improves vision in a form of childhood blindness
January 20, 2019 - Multiple sclerosis therapies delay progression of disability
January 20, 2019 - New study finds infrequent helmet use among bike share riders
January 20, 2019 - Clearing up information about corneal dystrophies
January 20, 2019 - Researchers describe new behavior in energy metabolism that refutes existing evidence
CNIO researchers link MASTL protein to origin of thrombocytopenia

CNIO researchers link MASTL protein to origin of thrombocytopenia

image_pdfDownload PDFimage_print

The Cell Division and Cancer Group of the Spanish National Cancer Research Centre (CNIO) has discovered that MASTL, the protein whose function in the organism has not yet been sufficiently investigated, plays an important role in controlling the cytoskeleton, the structure that gives shape to the cells, and enables their mobility and capacity for grouping. The researchers have managed to link the protein to the origin of an inherited thrombocytopenia and they point out that this discovery might have implications in the fight against cancer metastasis. The findings have been published in the Journal of Clinical Investigation.

Until now we have known that MASTL plays a role in the regulation of cell division, but not much else. In 2003, a team of American researchers identified a group of patients with inherited thrombocytopenia that had a mutation on the MASTL gene. Thrombocytopenia is a condition characterized by low levels of platelets, so the patients’ bodies cannot form clots and their symptoms include uncontrollable bleeding that can lead to hematomas and hemorrhages. The thrombocytopenia found in these patients, caused by the mutation on MASTL is known as autosomal dominant thrombocytopenia or thrombocytopenia-2.

CNIO researchers decided to study this particular mutation in the hope that it might lead them to discover more about the functions of the protein. “There were no previous connections that would tell us how a protein that regulates cell division could regulate the number of platelets”, says Begoña Hurtado, lead author of the paper together with Marianna Trakala.

To study this relationship they generated a line of genetically modified mice that were carriers of the same mutation found in the patients with thrombocytopenia-2. Together with the CNIO Proteomics Core Unit, led by Javier Muñoz, they discovered that the mutating platelets have a different morphology and different protein content that resulted in an altered cytoskeleton. The cytoskeleton gives stability and shape to the cell, apart from determining its mobility, playing the role of a ‘muscle’ cell. It also governs cell interaction and grouping. The study has discovered that the mutation on MASTL causes defects on this ‘muscle’, which, in the case of platelets, is fundamental in forming the clots that protect us from bleeding out.

Blocking the ‘escapist’ ability of metastatic cells

The observations have allowed us to identify the molecular bases of the mutation that causes the thrombocytopenia-2 in patients, which not only broaden our knowledge of the factors that participate in the origin of the disease, but also allow us to try out different therapies. The CNIO researchers were able to avoid the defect caused by the mutation by manipulating other enzymes of the cytoskeleton with chemical inhibitors that were already available at the clinic.

But the discovery that MASTL controls the cytoskeleton can have applications in cancer metastasis research. “The cytoskeleton is crucial for many cellular functions, but the cell signaling and adhesion to the medium properties (i.e. those associated with cellular migration and invasion) are the most important ones”, explains Marcos Malumbres, the Group leader and project manager.

Metastatic cells go through a special process of breaking away from their usual environment, they are able to modify their cell shape to ‘escape’ through the bloodstream and end up attaching themselves to new tissues starting the process of metastasis.

Malumbres’s Group has already discovered that MASTL could be a therapeutic target and that its inhibition could slow down the growth of breast tumors: recently they published their findings in the journal Cell Death & Differentiation where they describe how the levels of the protein are increased in some patients, and how its inhibition in experimental mouse models slowed down tumor development.

The next step in our investigation would be to analyze to what extent the expression of MASTL in tumors modulates its invasive or metastatic ability”, says Malumbres. The continuation of this work could open up new avenues for potential applications of MASTL inhibitors in cancer therapies.

Source:

https://www.cnio.es/ing/publicaciones/cnio-finds-origin-type-thrombocytopenia-caused-by-an-oncogene

About author

Related Articles